Dakota15
Senior Member (Voting Rights)
6/30, A Chat with Uma: From Foster Care to Harvard Neuroscientist: "The Choice to Live, Maternal Psychedelics & Post-Viral Chronic Illnesses with Dr. Ya’el Courtney“
"Covid was a horrible thing..but it drew public attention and scientific attention to post-viral conditions that affect the brain..”
““And the reason that was good is because there was this resurgence of interest in not only long Covid, but again, this idea of what happens when people get sick and don't get better. And resurgence of interest for a while at least translated to resurgence of funding, which meant that more labs started to ask these questions.”
“I'm particularly studying it from this idea that maybe it's because an autoimmune disease gets triggered.Others are studying it from other angles, but that's the angle that I'm taking. And so I'm studying this in long Covid. I'm studying this in post-treatment Lyme disease, and I have the freedom and flexibility in my lab to get actually samples from patients with other diseases that might be similar.There's another woman who's leading a small group on ME/CFS in my lab, so that's really her territory and really, really important work as well.”
"Covid was a horrible thing..but it drew public attention and scientific attention to post-viral conditions that affect the brain..”
““And the reason that was good is because there was this resurgence of interest in not only long Covid, but again, this idea of what happens when people get sick and don't get better. And resurgence of interest for a while at least translated to resurgence of funding, which meant that more labs started to ask these questions.”
“I'm particularly studying it from this idea that maybe it's because an autoimmune disease gets triggered.Others are studying it from other angles, but that's the angle that I'm taking. And so I'm studying this in long Covid. I'm studying this in post-treatment Lyme disease, and I have the freedom and flexibility in my lab to get actually samples from patients with other diseases that might be similar.There's another woman who's leading a small group on ME/CFS in my lab, so that's really her territory and really, really important work as well.”